JP2015528018A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015528018A5 JP2015528018A5 JP2015525460A JP2015525460A JP2015528018A5 JP 2015528018 A5 JP2015528018 A5 JP 2015528018A5 JP 2015525460 A JP2015525460 A JP 2015525460A JP 2015525460 A JP2015525460 A JP 2015525460A JP 2015528018 A5 JP2015528018 A5 JP 2015528018A5
- Authority
- JP
- Japan
- Prior art keywords
- amino
- naphthyridin
- oxy
- alkyl
- methylpentyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 125000005843 halogen group Chemical group 0.000 claims 17
- 229910052739 hydrogen Inorganic materials 0.000 claims 17
- 239000001257 hydrogen Substances 0.000 claims 17
- 150000002431 hydrogen Chemical class 0.000 claims 15
- 125000003118 aryl group Chemical group 0.000 claims 13
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 13
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims 12
- 125000006559 (C1-C3) alkylamino group Chemical group 0.000 claims 10
- 125000004356 hydroxy functional group Chemical group O* 0.000 claims 10
- 125000000217 alkyl group Chemical group 0.000 claims 9
- -1 C 1 -C 3 haloalkyl Chemical group 0.000 claims 8
- 150000003839 salts Chemical class 0.000 claims 7
- 150000001875 compounds Chemical class 0.000 claims 5
- 239000008194 pharmaceutical composition Substances 0.000 claims 5
- 125000006677 (C1-C3) haloalkoxy group Chemical group 0.000 claims 4
- 125000006699 (C1-C3) hydroxyalkyl group Chemical group 0.000 claims 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 4
- 125000006656 (C2-C4) alkenyl group Chemical group 0.000 claims 3
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 claims 3
- 125000004093 cyano group Chemical group *C#N 0.000 claims 3
- 125000000753 cycloalkyl group Chemical group 0.000 claims 3
- 125000004916 (C1-C6) alkylcarbonyl group Chemical group 0.000 claims 2
- LQOKRXHYUBRKJK-UHFFFAOYSA-N 3h-2,7-naphthyridin-4-one Chemical compound N1=CC=C2C(=O)CN=CC2=C1 LQOKRXHYUBRKJK-UHFFFAOYSA-N 0.000 claims 2
- XCKUSTFLSTVTCR-AWEZNQCLSA-N 8-[(2s)-2-amino-4-methylpentoxy]-2,6-dimethylbenzo[c][2,7]naphthyridin-5-one Chemical compound N1=C(C)C=C2C3=CC=C(OC[C@@H](N)CC(C)C)C=C3N(C)C(=O)C2=C1 XCKUSTFLSTVTCR-AWEZNQCLSA-N 0.000 claims 2
- HSHQEKUILXZVHT-ZDUSSCGKSA-N 8-[(2s)-2-amino-4-methylpentoxy]-4,6-dimethyl-9-(trifluoromethyl)benzo[c][2,7]naphthyridin-5-one Chemical compound CN1C(=O)C2=C(C)N=CC=C2C2=C1C=C(OC[C@@H](N)CC(C)C)C(C(F)(F)F)=C2 HSHQEKUILXZVHT-ZDUSSCGKSA-N 0.000 claims 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 2
- 208000002193 Pain Diseases 0.000 claims 2
- 125000001769 aryl amino group Chemical group 0.000 claims 2
- 125000004658 aryl carbonyl amino group Chemical group 0.000 claims 2
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims 2
- 125000006576 di-(C1-C3-alkyl)-aminocarbonyl group Chemical group 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 208000035475 disorder Diseases 0.000 claims 2
- 230000000694 effects Effects 0.000 claims 2
- 125000001072 heteroaryl group Chemical group 0.000 claims 2
- 208000004296 neuralgia Diseases 0.000 claims 2
- 208000021722 neuropathic pain Diseases 0.000 claims 2
- 229910052757 nitrogen Inorganic materials 0.000 claims 2
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 2
- SNOOUWRIMMFWNE-UHFFFAOYSA-M sodium;6-[(3,4,5-trimethoxybenzoyl)amino]hexanoate Chemical compound [Na+].COC1=CC(C(=O)NCCCCCC([O-])=O)=CC(OC)=C1OC SNOOUWRIMMFWNE-UHFFFAOYSA-M 0.000 claims 2
- LOZLKDVGPQCIRZ-INIZCTEOSA-N 4,6-dimethyl-8-[(2s)-4-methyl-2-(methylamino)pentoxy]-5-oxobenzo[c][2,7]naphthyridine-9-carbonitrile Chemical compound CN1C(=O)C2=C(C)N=CC=C2C2=C1C=C(OC[C@@H](NC)CC(C)C)C(C#N)=C2 LOZLKDVGPQCIRZ-INIZCTEOSA-N 0.000 claims 1
- WWWKOVDRVDVLRG-HNNXBMFYSA-N 4,6-dimethyl-8-[(2s)-4-methyl-2-(methylamino)pentoxy]benzo[c][2,7]naphthyridin-5-one Chemical compound N1=CC=C2C3=CC=C(OC[C@@H](NC)CC(C)C)C=C3N(C)C(=O)C2=C1C WWWKOVDRVDVLRG-HNNXBMFYSA-N 0.000 claims 1
- GIJACGNPPUYZEJ-LBPRGKRZSA-N 4-amino-8-[(2s)-2-amino-4-methylpentoxy]-6-methylbenzo[c][2,7]naphthyridin-5-one Chemical compound N1=CC=C2C3=CC=C(OC[C@@H](N)CC(C)C)C=C3N(C)C(=O)C2=C1N GIJACGNPPUYZEJ-LBPRGKRZSA-N 0.000 claims 1
- FCBKDNGEEHZOJJ-NSHDSACASA-N 4-amino-8-[(2s)-2-amino-4-methylpentoxy]-9-fluoro-6-methylbenzo[c][2,7]naphthyridin-5-one Chemical compound CN1C(=O)C2=C(N)N=CC=C2C2=C1C=C(OC[C@@H](N)CC(C)C)C(F)=C2 FCBKDNGEEHZOJJ-NSHDSACASA-N 0.000 claims 1
- MCBJOMAHTKEJOM-UHFFFAOYSA-N 6-methyl-8-(piperidin-2-ylmethoxy)benzo[c][2,7]naphthyridin-5-one Chemical compound C=1C=C2C3=CC=NC=C3C(=O)N(C)C2=CC=1OCC1CCCCN1 MCBJOMAHTKEJOM-UHFFFAOYSA-N 0.000 claims 1
- OAGROMXPCACYDF-AWEZNQCLSA-N 6-methyl-8-[(2s)-4-methyl-2-(methylamino)pentoxy]benzo[c][2,7]naphthyridin-5-one Chemical compound N1=CC=C2C3=CC=C(OC[C@@H](NC)CC(C)C)C=C3N(C)C(=O)C2=C1 OAGROMXPCACYDF-AWEZNQCLSA-N 0.000 claims 1
- KLLKJQSKBGRMFP-UHFFFAOYSA-N 8-(2-amino-2,4-dimethylpentoxy)-1-fluoro-6-methylbenzo[c][2,7]naphthyridin-5-one Chemical compound N1=CC(F)=C2C3=CC=C(OCC(C)(N)CC(C)C)C=C3N(C)C(=O)C2=C1 KLLKJQSKBGRMFP-UHFFFAOYSA-N 0.000 claims 1
- KAXLZTZBXHYOSC-UHFFFAOYSA-N 8-(2-amino-2,4-dimethylpentoxy)-4,6-dimethylbenzo[c][2,7]naphthyridin-5-one Chemical compound N1=CC=C2C3=CC=C(OCC(C)(N)CC(C)C)C=C3N(C)C(=O)C2=C1C KAXLZTZBXHYOSC-UHFFFAOYSA-N 0.000 claims 1
- NBHCBBXZBQCGBZ-UHFFFAOYSA-N 8-(2-amino-2,4-dimethylpentoxy)-7-fluoro-4,6-dimethylbenzo[c][2,7]naphthyridin-5-one Chemical compound C1=NC(C)=C2C(=O)N(C)C3=C(F)C(OCC(C)(N)CC(C)C)=CC=C3C2=C1 NBHCBBXZBQCGBZ-UHFFFAOYSA-N 0.000 claims 1
- KMUIQNNSUSDHKH-UHFFFAOYSA-N 8-(2-amino-2,4-dimethylpentoxy)-7-fluoro-4-methyl-6h-benzo[c][2,7]naphthyridin-5-one Chemical compound C1=NC(C)=C2C(=O)NC3=C(F)C(OCC(C)(N)CC(C)C)=CC=C3C2=C1 KMUIQNNSUSDHKH-UHFFFAOYSA-N 0.000 claims 1
- CMHHZVVLJLNEHM-UHFFFAOYSA-N 8-(2-amino-2,4-dimethylpentoxy)-9-chloro-4,6-dimethylbenzo[c][2,7]naphthyridin-5-one Chemical compound CN1C(=O)C2=C(C)N=CC=C2C2=C1C=C(OCC(C)(N)CC(C)C)C(Cl)=C2 CMHHZVVLJLNEHM-UHFFFAOYSA-N 0.000 claims 1
- XKLGKAZUFOBXOV-UHFFFAOYSA-N 8-(2-amino-2,4-dimethylpentoxy)-9-fluoro-4-methyl-6h-benzo[c][2,7]naphthyridin-5-one Chemical compound N1C(=O)C2=C(C)N=CC=C2C2=C1C=C(OCC(C)(N)CC(C)C)C(F)=C2 XKLGKAZUFOBXOV-UHFFFAOYSA-N 0.000 claims 1
- STLIWKILGDSCFT-UHFFFAOYSA-N 8-(2-amino-2,4-dimethylpentoxy)-9-methoxy-4,6-dimethylbenzo[c][2,7]naphthyridin-5-one Chemical compound CN1C(=O)C2=C(C)N=CC=C2C2=C1C=C(OCC(C)(N)CC(C)C)C(OC)=C2 STLIWKILGDSCFT-UHFFFAOYSA-N 0.000 claims 1
- HZWYAONXPMPCBU-UHFFFAOYSA-N 8-(2-amino-4,4,4-trifluorobutoxy)-6-methylbenzo[c][2,7]naphthyridin-5-one Chemical compound C1=NC=C2C(=O)N(C)C3=CC(OCC(N)CC(F)(F)F)=CC=C3C2=C1 HZWYAONXPMPCBU-UHFFFAOYSA-N 0.000 claims 1
- FXZTVDZYBASRIS-UHFFFAOYSA-N 8-(2-amino-5,5,5-trifluoropentoxy)-4,6-dimethyl-5-oxobenzo[c][2,7]naphthyridine-9-carbonitrile Chemical compound C12=CC(C#N)=C(OCC(N)CCC(F)(F)F)C=C2N(C)C(=O)C2=C1C=CN=C2C FXZTVDZYBASRIS-UHFFFAOYSA-N 0.000 claims 1
- ZSCOHFKAMHDAOA-UHFFFAOYSA-N 8-(2-amino-5,5,5-trifluoropentoxy)-6-methyl-5-oxobenzo[c][2,7]naphthyridine-9-carbonitrile Chemical compound C1=NC=C2C(=O)N(C)C3=CC(OCC(N)CCC(F)(F)F)=C(C#N)C=C3C2=C1 ZSCOHFKAMHDAOA-UHFFFAOYSA-N 0.000 claims 1
- XWZXCIPLOWRHAC-UHFFFAOYSA-N 8-(2-amino-5,5,5-trifluoropentoxy)-6-methylbenzo[c][2,7]naphthyridin-5-one Chemical compound C1=NC=C2C(=O)N(C)C3=CC(OCC(N)CCC(F)(F)F)=CC=C3C2=C1 XWZXCIPLOWRHAC-UHFFFAOYSA-N 0.000 claims 1
- KAXLZTZBXHYOSC-OAQYLSRUSA-N 8-[(2r)-2-amino-2,4-dimethylpentoxy]-4,6-dimethylbenzo[c][2,7]naphthyridin-5-one Chemical compound N1=CC=C2C3=CC=C(OC[C@](C)(N)CC(C)C)C=C3N(C)C(=O)C2=C1C KAXLZTZBXHYOSC-OAQYLSRUSA-N 0.000 claims 1
- YRGHZZQVZHUGHW-LLVKDONJSA-N 8-[(2r)-2-amino-4,4,4-trifluorobutoxy]-4,6-dimethylbenzo[c][2,7]naphthyridin-5-one Chemical compound C12=CC=C(OC[C@H](N)CC(F)(F)F)C=C2N(C)C(=O)C2=C1C=CN=C2C YRGHZZQVZHUGHW-LLVKDONJSA-N 0.000 claims 1
- NQXBZPJVVGIFBJ-OAHLLOKOSA-N 8-[(2r)-2-amino-4-methylpentoxy]-4,6-dimethyl-5-oxobenzo[c][2,7]naphthyridine-9-carbonitrile Chemical compound CN1C(=O)C2=C(C)N=CC=C2C2=C1C=C(OC[C@H](N)CC(C)C)C(C#N)=C2 NQXBZPJVVGIFBJ-OAHLLOKOSA-N 0.000 claims 1
- HRMGBYSRWUAWIG-CQSZACIVSA-N 8-[(2r)-2-amino-4-methylpentoxy]-4,6-dimethylbenzo[c][2,7]naphthyridin-5-one Chemical compound N1=CC=C2C3=CC=C(OC[C@H](N)CC(C)C)C=C3N(C)C(=O)C2=C1C HRMGBYSRWUAWIG-CQSZACIVSA-N 0.000 claims 1
- URECUINDIIRBJP-CYBMUJFWSA-N 8-[(2r)-2-amino-4-methylpentoxy]-9-chloro-4,6-dimethylbenzo[c][2,7]naphthyridin-5-one Chemical compound CN1C(=O)C2=C(C)N=CC=C2C2=C1C=C(OC[C@H](N)CC(C)C)C(Cl)=C2 URECUINDIIRBJP-CYBMUJFWSA-N 0.000 claims 1
- RXVZYVSEPCPLIQ-INIZCTEOSA-N 8-[(2s)-2-(dimethylamino)-4-methylpentoxy]-4,6-dimethylbenzo[c][2,7]naphthyridin-5-one Chemical compound N1=CC=C2C3=CC=C(OC[C@H](CC(C)C)N(C)C)C=C3N(C)C(=O)C2=C1C RXVZYVSEPCPLIQ-INIZCTEOSA-N 0.000 claims 1
- GSMCIADOCFDNFO-HNNXBMFYSA-N 8-[(2s)-2-(dimethylamino)-4-methylpentoxy]-6-methylbenzo[c][2,7]naphthyridin-5-one Chemical compound N1=CC=C2C3=CC=C(OC[C@H](CC(C)C)N(C)C)C=C3N(C)C(=O)C2=C1 GSMCIADOCFDNFO-HNNXBMFYSA-N 0.000 claims 1
- KAXLZTZBXHYOSC-NRFANRHFSA-N 8-[(2s)-2-amino-2,4-dimethylpentoxy]-4,6-dimethylbenzo[c][2,7]naphthyridin-5-one Chemical compound N1=CC=C2C3=CC=C(OC[C@@](C)(N)CC(C)C)C=C3N(C)C(=O)C2=C1C KAXLZTZBXHYOSC-NRFANRHFSA-N 0.000 claims 1
- OOOPDKTUMJEDEK-INIZCTEOSA-N 8-[(2s)-2-amino-3-cyclobutylpropoxy]-4,6,9-trimethylbenzo[c][2,7]naphthyridin-5-one Chemical compound C([C@H](N)COC1=CC2=C(C3=CC=NC(C)=C3C(=O)N2C)C=C1C)C1CCC1 OOOPDKTUMJEDEK-INIZCTEOSA-N 0.000 claims 1
- SPLKFCCVHVFPQH-HNNXBMFYSA-N 8-[(2s)-2-amino-3-cyclobutylpropoxy]-4,6-dimethylbenzo[c][2,7]naphthyridin-5-one Chemical compound C([C@H](N)COC1=CC=C2C=3C=CN=C(C=3C(=O)N(C)C2=C1)C)C1CCC1 SPLKFCCVHVFPQH-HNNXBMFYSA-N 0.000 claims 1
- SNEOIKHHDVLVOX-AWEZNQCLSA-N 8-[(2s)-2-amino-3-cyclobutylpropoxy]-9-chloro-4,6-dimethylbenzo[c][2,7]naphthyridin-5-one Chemical compound C([C@H](N)COC1=C(Cl)C=C2C=3C=CN=C(C=3C(=O)N(C)C2=C1)C)C1CCC1 SNEOIKHHDVLVOX-AWEZNQCLSA-N 0.000 claims 1
- QWYVFLDYWGJEQU-HNNXBMFYSA-N 8-[(2s)-2-amino-3-cyclopropylpropoxy]-4,6,9-trimethylbenzo[c][2,7]naphthyridin-5-one Chemical compound C([C@H](N)COC1=CC2=C(C3=CC=NC(C)=C3C(=O)N2C)C=C1C)C1CC1 QWYVFLDYWGJEQU-HNNXBMFYSA-N 0.000 claims 1
- NJUOJAQINHVMBT-AWEZNQCLSA-N 8-[(2s)-2-amino-3-cyclopropylpropoxy]-4,6-dimethylbenzo[c][2,7]naphthyridin-5-one Chemical compound C([C@H](N)COC1=CC=C2C=3C=CN=C(C=3C(=O)N(C)C2=C1)C)C1CC1 NJUOJAQINHVMBT-AWEZNQCLSA-N 0.000 claims 1
- UVIQIJWVZHLOOF-ZDUSSCGKSA-N 8-[(2s)-2-amino-3-cyclopropylpropoxy]-9-chloro-4,6-dimethylbenzo[c][2,7]naphthyridin-5-one Chemical compound C([C@H](N)COC1=C(Cl)C=C2C=3C=CN=C(C=3C(=O)N(C)C2=C1)C)C1CC1 UVIQIJWVZHLOOF-ZDUSSCGKSA-N 0.000 claims 1
- YGIQORZXXQTXBN-ZDUSSCGKSA-N 8-[(2s)-2-amino-3-propan-2-yloxypropoxy]-6-methylbenzo[c][2,7]naphthyridin-5-one Chemical compound N1=CC=C2C3=CC=C(OC[C@@H](N)COC(C)C)C=C3N(C)C(=O)C2=C1 YGIQORZXXQTXBN-ZDUSSCGKSA-N 0.000 claims 1
- YRGHZZQVZHUGHW-NSHDSACASA-N 8-[(2s)-2-amino-4,4,4-trifluorobutoxy]-4,6-dimethylbenzo[c][2,7]naphthyridin-5-one Chemical compound C12=CC=C(OC[C@@H](N)CC(F)(F)F)C=C2N(C)C(=O)C2=C1C=CN=C2C YRGHZZQVZHUGHW-NSHDSACASA-N 0.000 claims 1
- WHQDGHKLJVQMRP-NSHDSACASA-N 8-[(2s)-2-amino-4,4-difluoropentoxy]-6-methylbenzo[c][2,7]naphthyridin-5-one Chemical compound C1=NC=C2C(=O)N(C)C3=CC(OC[C@@H](N)CC(C)(F)F)=CC=C3C2=C1 WHQDGHKLJVQMRP-NSHDSACASA-N 0.000 claims 1
- NLRSBHGTESEGQM-LBPRGKRZSA-N 8-[(2s)-2-amino-4-methylpentoxy]-1-fluoro-6-methylbenzo[c][2,7]naphthyridin-5-one Chemical compound N1=CC(F)=C2C3=CC=C(OC[C@@H](N)CC(C)C)C=C3N(C)C(=O)C2=C1 NLRSBHGTESEGQM-LBPRGKRZSA-N 0.000 claims 1
- XVIGNJJPLOWARI-ZDUSSCGKSA-N 8-[(2s)-2-amino-4-methylpentoxy]-1-methoxy-6-methylbenzo[c][2,7]naphthyridin-5-one Chemical compound C12=CC=C(OC[C@@H](N)CC(C)C)C=C2N(C)C(=O)C2=C1C(OC)=CN=C2 XVIGNJJPLOWARI-ZDUSSCGKSA-N 0.000 claims 1
- VKDHJNPPKCHVLP-HNNXBMFYSA-N 8-[(2s)-2-amino-4-methylpentoxy]-4,6,9-trimethylbenzo[c][2,7]naphthyridin-5-one Chemical compound CN1C(=O)C2=C(C)N=CC=C2C2=C1C=C(OC[C@@H](N)CC(C)C)C(C)=C2 VKDHJNPPKCHVLP-HNNXBMFYSA-N 0.000 claims 1
- NQXBZPJVVGIFBJ-HNNXBMFYSA-N 8-[(2s)-2-amino-4-methylpentoxy]-4,6-dimethyl-5-oxobenzo[c][2,7]naphthyridine-9-carbonitrile Chemical compound CN1C(=O)C2=C(C)N=CC=C2C2=C1C=C(OC[C@@H](N)CC(C)C)C(C#N)=C2 NQXBZPJVVGIFBJ-HNNXBMFYSA-N 0.000 claims 1
- BLTIFWQUIKJLLO-ZDUSSCGKSA-N 8-[(2s)-2-amino-4-methylpentoxy]-4,6-dimethyl-5-oxobenzo[c][2,7]naphthyridine-9-carboxamide Chemical compound CN1C(=O)C2=C(C)N=CC=C2C2=C1C=C(OC[C@@H](N)CC(C)C)C(C(N)=O)=C2 BLTIFWQUIKJLLO-ZDUSSCGKSA-N 0.000 claims 1
- PBOYTVVOMMRCKA-HNNXBMFYSA-N 8-[(2s)-2-amino-4-methylpentoxy]-4,6-dimethyl-9-(1,3-oxazol-5-yl)benzo[c][2,7]naphthyridin-5-one Chemical compound CC(C)C[C@H](N)COC1=CC=2N(C)C(=O)C3=C(C)N=CC=C3C=2C=C1C1=CN=CO1 PBOYTVVOMMRCKA-HNNXBMFYSA-N 0.000 claims 1
- WVWZWEDZULHZHM-HNNXBMFYSA-N 8-[(2s)-2-amino-4-methylpentoxy]-4,6-dimethyl-9-(1,3-thiazol-5-yl)benzo[c][2,7]naphthyridin-5-one Chemical compound CC(C)C[C@H](N)COC1=CC=2N(C)C(=O)C3=C(C)N=CC=C3C=2C=C1C1=CN=CS1 WVWZWEDZULHZHM-HNNXBMFYSA-N 0.000 claims 1
- VNYWTAUYKHVQTO-AWEZNQCLSA-N 8-[(2s)-2-amino-4-methylpentoxy]-4,6-dimethyl-9-methylsulfonylbenzo[c][2,7]naphthyridin-5-one Chemical compound CN1C(=O)C2=C(C)N=CC=C2C2=C1C=C(OC[C@@H](N)CC(C)C)C(S(C)(=O)=O)=C2 VNYWTAUYKHVQTO-AWEZNQCLSA-N 0.000 claims 1
- CJYBTGCGPOINHK-KRWDZBQOSA-N 8-[(2s)-2-amino-4-methylpentoxy]-4,6-dimethyl-9-pyridin-2-ylbenzo[c][2,7]naphthyridin-5-one Chemical compound CC(C)C[C@H](N)COC1=CC=2N(C)C(=O)C3=C(C)N=CC=C3C=2C=C1C1=CC=CC=N1 CJYBTGCGPOINHK-KRWDZBQOSA-N 0.000 claims 1
- HRMGBYSRWUAWIG-AWEZNQCLSA-N 8-[(2s)-2-amino-4-methylpentoxy]-4,6-dimethylbenzo[c][2,7]naphthyridin-5-one Chemical compound N1=CC=C2C3=CC=C(OC[C@@H](N)CC(C)C)C=C3N(C)C(=O)C2=C1C HRMGBYSRWUAWIG-AWEZNQCLSA-N 0.000 claims 1
- BGLUCWKQMAHNGQ-LBPRGKRZSA-N 8-[(2s)-2-amino-4-methylpentoxy]-4-(difluoromethyl)-6-methylbenzo[c][2,7]naphthyridin-5-one Chemical compound N1=CC=C2C3=CC=C(OC[C@@H](N)CC(C)C)C=C3N(C)C(=O)C2=C1C(F)F BGLUCWKQMAHNGQ-LBPRGKRZSA-N 0.000 claims 1
- SVROKGXYLBYIMC-IBGZPJMESA-N 8-[(2s)-2-amino-4-methylpentoxy]-4-[(4-methoxyphenyl)methylamino]-6-methylbenzo[c][2,7]naphthyridin-5-one Chemical compound C1=CC(OC)=CC=C1CNC1=NC=CC2=C1C(=O)N(C)C1=CC(OC[C@@H](N)CC(C)C)=CC=C12 SVROKGXYLBYIMC-IBGZPJMESA-N 0.000 claims 1
- LBECDWCCXFEOTO-ZDUSSCGKSA-N 8-[(2s)-2-amino-4-methylpentoxy]-4-methoxy-6-methylbenzo[c][2,7]naphthyridin-5-one Chemical compound C12=CC=C(OC[C@@H](N)CC(C)C)C=C2N(C)C(=O)C2=C1C=CN=C2OC LBECDWCCXFEOTO-ZDUSSCGKSA-N 0.000 claims 1
- KVRKKRBPFCLMMG-ZDUSSCGKSA-N 8-[(2s)-2-amino-4-methylpentoxy]-4-methyl-6h-benzo[c][2,7]naphthyridin-5-one Chemical compound N1=CC=C2C3=CC=C(OC[C@@H](N)CC(C)C)C=C3NC(=O)C2=C1C KVRKKRBPFCLMMG-ZDUSSCGKSA-N 0.000 claims 1
- YPEZYWFTKZJJJZ-AWEZNQCLSA-N 8-[(2s)-2-amino-4-methylpentoxy]-6,9-dimethylbenzo[c][2,7]naphthyridin-5-one Chemical compound CN1C(=O)C2=CN=CC=C2C2=C1C=C(OC[C@@H](N)CC(C)C)C(C)=C2 YPEZYWFTKZJJJZ-AWEZNQCLSA-N 0.000 claims 1
- ZLWTXUUWGKBYQB-ZDUSSCGKSA-N 8-[(2s)-2-amino-4-methylpentoxy]-6-(2,2,2-trifluoroethyl)benzo[c][2,7]naphthyridin-5-one Chemical compound N1=CC=C2C3=CC=C(OC[C@@H](N)CC(C)C)C=C3N(CC(F)(F)F)C(=O)C2=C1 ZLWTXUUWGKBYQB-ZDUSSCGKSA-N 0.000 claims 1
- HRNXRDKJFHAEEN-AWEZNQCLSA-N 8-[(2s)-2-amino-4-methylpentoxy]-6-(2-hydroxyethyl)benzo[c][2,7]naphthyridin-5-one Chemical compound N1=CC=C2C3=CC=C(OC[C@@H](N)CC(C)C)C=C3N(CCO)C(=O)C2=C1 HRNXRDKJFHAEEN-AWEZNQCLSA-N 0.000 claims 1
- IHAGWGCKKJXHRG-INIZCTEOSA-N 8-[(2s)-2-amino-4-methylpentoxy]-6-(2-methoxyethyl)-4-methylbenzo[c][2,7]naphthyridin-5-one Chemical compound C1=NC(C)=C2C(=O)N(CCOC)C3=CC(OC[C@@H](N)CC(C)C)=CC=C3C2=C1 IHAGWGCKKJXHRG-INIZCTEOSA-N 0.000 claims 1
- ODUGXJAXPWAZJC-HNNXBMFYSA-N 8-[(2s)-2-amino-4-methylpentoxy]-6-(2-methoxyethyl)benzo[c][2,7]naphthyridin-5-one Chemical compound C1=NC=C2C(=O)N(CCOC)C3=CC(OC[C@@H](N)CC(C)C)=CC=C3C2=C1 ODUGXJAXPWAZJC-HNNXBMFYSA-N 0.000 claims 1
- APIXEYSCHSPEJC-INIZCTEOSA-N 8-[(2s)-2-amino-4-methylpentoxy]-6-(cyclopropylmethyl)benzo[c][2,7]naphthyridin-5-one Chemical compound C=1C(OC[C@@H](N)CC(C)C)=CC=C(C2=CC=NC=C2C2=O)C=1N2CC1CC1 APIXEYSCHSPEJC-INIZCTEOSA-N 0.000 claims 1
- JOCMZPAMMJDEEF-IBGZPJMESA-N 8-[(2s)-2-amino-4-methylpentoxy]-6-benzylbenzo[c][2,7]naphthyridin-5-one Chemical compound C=1C(OC[C@@H](N)CC(C)C)=CC=C(C2=CC=NC=C2C2=O)C=1N2CC1=CC=CC=C1 JOCMZPAMMJDEEF-IBGZPJMESA-N 0.000 claims 1
- OFNHFLZBMXWFJV-AWEZNQCLSA-N 8-[(2s)-2-amino-4-methylpentoxy]-6-methyl-5-oxobenzo[c][2,7]naphthyridine-9-carbonitrile Chemical compound CN1C(=O)C2=CN=CC=C2C2=C1C=C(OC[C@@H](N)CC(C)C)C(C#N)=C2 OFNHFLZBMXWFJV-AWEZNQCLSA-N 0.000 claims 1
- FGATYYWDIQMZBZ-AWEZNQCLSA-N 8-[(2s)-2-amino-4-methylpentoxy]-6-methyl-9-(1,3-oxazol-5-yl)benzo[c][2,7]naphthyridin-5-one Chemical compound CC(C)C[C@H](N)COC1=CC=2N(C)C(=O)C3=CN=CC=C3C=2C=C1C1=CN=CO1 FGATYYWDIQMZBZ-AWEZNQCLSA-N 0.000 claims 1
- QLTHRQXGSXPWOS-HNNXBMFYSA-N 8-[(2s)-2-amino-4-methylpentoxy]-6-methyl-9-propan-2-ylbenzo[c][2,7]naphthyridin-5-one Chemical compound CN1C(=O)C2=CN=CC=C2C2=C1C=C(OC[C@@H](N)CC(C)C)C(C(C)C)=C2 QLTHRQXGSXPWOS-HNNXBMFYSA-N 0.000 claims 1
- UVIHYWTURRDUAZ-ZDUSSCGKSA-N 8-[(2s)-2-amino-4-methylpentoxy]-6-methylbenzo[c][2,7]naphthyridin-5-one Chemical compound N1=CC=C2C3=CC=C(OC[C@@H](N)CC(C)C)C=C3N(C)C(=O)C2=C1 UVIHYWTURRDUAZ-ZDUSSCGKSA-N 0.000 claims 1
- WWGYWTPSBKHRKT-HNNXBMFYSA-N 8-[(2s)-2-amino-4-methylpentoxy]-6-prop-2-enylbenzo[c][2,7]naphthyridin-5-one Chemical compound N1=CC=C2C3=CC=C(OC[C@@H](N)CC(C)C)C=C3N(CC=C)C(=O)C2=C1 WWGYWTPSBKHRKT-HNNXBMFYSA-N 0.000 claims 1
- AQOSFDACVBCBQG-HNNXBMFYSA-N 8-[(2s)-2-amino-4-methylpentoxy]-6-propan-2-ylbenzo[c][2,7]naphthyridin-5-one Chemical compound N1=CC=C2C3=CC=C(OC[C@@H](N)CC(C)C)C=C3N(C(C)C)C(=O)C2=C1 AQOSFDACVBCBQG-HNNXBMFYSA-N 0.000 claims 1
- ATCROYCGFZTPSQ-LBPRGKRZSA-N 8-[(2s)-2-amino-4-methylpentoxy]-6h-benzo[c][2,7]naphthyridin-5-one Chemical compound N1=CC=C2C3=CC=C(OC[C@@H](N)CC(C)C)C=C3NC(=O)C2=C1 ATCROYCGFZTPSQ-LBPRGKRZSA-N 0.000 claims 1
- OMEXFLHXDATQQV-NSHDSACASA-N 8-[(2s)-2-amino-4-methylpentoxy]-7,9-dichloro-6-methylbenzo[c][2,7]naphthyridin-5-one Chemical compound C1=NC=C2C(=O)N(C)C3=C(Cl)C(OC[C@@H](N)CC(C)C)=C(Cl)C=C3C2=C1 OMEXFLHXDATQQV-NSHDSACASA-N 0.000 claims 1
- OYOIIDJCDNWRLV-ZDUSSCGKSA-N 8-[(2s)-2-amino-4-methylpentoxy]-7-chloro-4,6-dimethylbenzo[c][2,7]naphthyridin-5-one Chemical compound C1=NC(C)=C2C(=O)N(C)C3=C(Cl)C(OC[C@@H](N)CC(C)C)=CC=C3C2=C1 OYOIIDJCDNWRLV-ZDUSSCGKSA-N 0.000 claims 1
- WSKQQUBBBVNHFA-ZDUSSCGKSA-N 8-[(2s)-2-amino-4-methylpentoxy]-7-fluoro-4,6-dimethylbenzo[c][2,7]naphthyridin-5-one Chemical compound C1=NC(C)=C2C(=O)N(C)C3=C(F)C(OC[C@@H](N)CC(C)C)=CC=C3C2=C1 WSKQQUBBBVNHFA-ZDUSSCGKSA-N 0.000 claims 1
- IBOVYPMCAGZYGE-LBPRGKRZSA-N 8-[(2s)-2-amino-4-methylpentoxy]-7-fluoro-4-methyl-6h-benzo[c][2,7]naphthyridin-5-one Chemical compound C1=NC(C)=C2C(=O)NC3=C(F)C(OC[C@@H](N)CC(C)C)=CC=C3C2=C1 IBOVYPMCAGZYGE-LBPRGKRZSA-N 0.000 claims 1
- CRIWGRHBFYLTLV-ZDUSSCGKSA-N 8-[(2s)-2-amino-4-methylpentoxy]-7-methoxy-4-methyl-6h-benzo[c][2,7]naphthyridin-5-one Chemical compound C12=CC=NC(C)=C2C(=O)NC2=C1C=CC(OC[C@@H](N)CC(C)C)=C2OC CRIWGRHBFYLTLV-ZDUSSCGKSA-N 0.000 claims 1
- UDYNBTZVRFJLDX-LOACHALJSA-N 8-[(2s)-2-amino-4-methylpentoxy]-9-(1-hydroxyethyl)-4,6-dimethylbenzo[c][2,7]naphthyridin-5-one Chemical compound CN1C(=O)C2=C(C)N=CC=C2C2=C1C=C(OC[C@@H](N)CC(C)C)C(C(C)O)=C2 UDYNBTZVRFJLDX-LOACHALJSA-N 0.000 claims 1
- USAMSFVGHFFXCT-HNNXBMFYSA-N 8-[(2s)-2-amino-4-methylpentoxy]-9-(2-hydroxypropan-2-yl)-4,6-dimethylbenzo[c][2,7]naphthyridin-5-one Chemical compound CN1C(=O)C2=C(C)N=CC=C2C2=C1C=C(OC[C@@H](N)CC(C)C)C(C(C)(C)O)=C2 USAMSFVGHFFXCT-HNNXBMFYSA-N 0.000 claims 1
- CUYXOTOYPMKKDG-SFHVURJKSA-N 8-[(2s)-2-amino-4-methylpentoxy]-9-(4-fluorophenyl)-6-methylbenzo[c][2,7]naphthyridin-5-one Chemical compound CC(C)C[C@H](N)COC1=CC=2N(C)C(=O)C3=CN=CC=C3C=2C=C1C1=CC=C(F)C=C1 CUYXOTOYPMKKDG-SFHVURJKSA-N 0.000 claims 1
- ORQYAHOYSVQHFF-ZDUSSCGKSA-N 8-[(2s)-2-amino-4-methylpentoxy]-9-(difluoromethoxy)-4,6-dimethylbenzo[c][2,7]naphthyridin-5-one Chemical compound CN1C(=O)C2=C(C)N=CC=C2C2=C1C=C(OC[C@@H](N)CC(C)C)C(OC(F)F)=C2 ORQYAHOYSVQHFF-ZDUSSCGKSA-N 0.000 claims 1
- AXHQXXMTZWZPDS-ZDUSSCGKSA-N 8-[(2s)-2-amino-4-methylpentoxy]-9-(difluoromethyl)-4,6-dimethylbenzo[c][2,7]naphthyridin-5-one Chemical compound CN1C(=O)C2=C(C)N=CC=C2C2=C1C=C(OC[C@@H](N)CC(C)C)C(C(F)F)=C2 AXHQXXMTZWZPDS-ZDUSSCGKSA-N 0.000 claims 1
- NWYXJWAMZICQET-HNNXBMFYSA-N 8-[(2s)-2-amino-4-methylpentoxy]-9-(hydroxymethyl)-4,6-dimethylbenzo[c][2,7]naphthyridin-5-one Chemical compound CN1C(=O)C2=C(C)N=CC=C2C2=C1C=C(OC[C@@H](N)CC(C)C)C(CO)=C2 NWYXJWAMZICQET-HNNXBMFYSA-N 0.000 claims 1
- BJNSPVVEWIIBBR-INIZCTEOSA-N 8-[(2s)-2-amino-4-methylpentoxy]-9-(methoxymethyl)-4,6-dimethylbenzo[c][2,7]naphthyridin-5-one Chemical compound CN1C(=O)C2=C(C)N=CC=C2C2=C1C=C(OC[C@@H](N)CC(C)C)C(COC)=C2 BJNSPVVEWIIBBR-INIZCTEOSA-N 0.000 claims 1
- CCHPJDYBRNVSFQ-LBPRGKRZSA-N 8-[(2s)-2-amino-4-methylpentoxy]-9-bromo-4-methyl-6h-benzo[c][2,7]naphthyridin-5-one Chemical compound N1C(=O)C2=C(C)N=CC=C2C2=C1C=C(OC[C@@H](N)CC(C)C)C(Br)=C2 CCHPJDYBRNVSFQ-LBPRGKRZSA-N 0.000 claims 1
- DNJVIWQGOSPTGR-LBPRGKRZSA-N 8-[(2s)-2-amino-4-methylpentoxy]-9-bromo-6-methylbenzo[c][2,7]naphthyridin-5-one Chemical compound CN1C(=O)C2=CN=CC=C2C2=C1C=C(OC[C@@H](N)CC(C)C)C(Br)=C2 DNJVIWQGOSPTGR-LBPRGKRZSA-N 0.000 claims 1
- KAPLDTONLWMQIE-NSHDSACASA-N 8-[(2s)-2-amino-4-methylpentoxy]-9-bromo-7-fluoro-4-methyl-6h-benzo[c][2,7]naphthyridin-5-one Chemical compound C1=NC(C)=C2C(=O)NC3=C(F)C(OC[C@@H](N)CC(C)C)=C(Br)C=C3C2=C1 KAPLDTONLWMQIE-NSHDSACASA-N 0.000 claims 1
- DWWYXDNMFIWINY-ZDUSSCGKSA-N 8-[(2s)-2-amino-4-methylpentoxy]-9-chloro-2,6-dimethylbenzo[c][2,7]naphthyridin-5-one Chemical compound CN1C(=O)C2=CN=C(C)C=C2C2=C1C=C(OC[C@@H](N)CC(C)C)C(Cl)=C2 DWWYXDNMFIWINY-ZDUSSCGKSA-N 0.000 claims 1
- URECUINDIIRBJP-ZDUSSCGKSA-N 8-[(2s)-2-amino-4-methylpentoxy]-9-chloro-4,6-dimethylbenzo[c][2,7]naphthyridin-5-one Chemical compound CN1C(=O)C2=C(C)N=CC=C2C2=C1C=C(OC[C@@H](N)CC(C)C)C(Cl)=C2 URECUINDIIRBJP-ZDUSSCGKSA-N 0.000 claims 1
- HYRWSXHWUJUTDU-HNNXBMFYSA-N 8-[(2s)-2-amino-4-methylpentoxy]-9-chloro-6-(2-methoxyethyl)-4-methylbenzo[c][2,7]naphthyridin-5-one Chemical compound C1=NC(C)=C2C(=O)N(CCOC)C3=CC(OC[C@@H](N)CC(C)C)=C(Cl)C=C3C2=C1 HYRWSXHWUJUTDU-HNNXBMFYSA-N 0.000 claims 1
- INTHQLAUYFYAOM-LBPRGKRZSA-N 8-[(2s)-2-amino-4-methylpentoxy]-9-chloro-6-methylbenzo[c][2,7]naphthyridin-5-one Chemical compound CN1C(=O)C2=CN=CC=C2C2=C1C=C(OC[C@@H](N)CC(C)C)C(Cl)=C2 INTHQLAUYFYAOM-LBPRGKRZSA-N 0.000 claims 1
- IOELABXSEUZEQB-LBPRGKRZSA-N 8-[(2s)-2-amino-4-methylpentoxy]-9-chloro-7-fluoro-4,6-dimethylbenzo[c][2,7]naphthyridin-5-one Chemical compound C1=NC(C)=C2C(=O)N(C)C3=C(F)C(OC[C@@H](N)CC(C)C)=C(Cl)C=C3C2=C1 IOELABXSEUZEQB-LBPRGKRZSA-N 0.000 claims 1
- JKZORRCCLSIZMM-HNNXBMFYSA-N 8-[(2s)-2-amino-4-methylpentoxy]-9-cyclopropyl-6-methylbenzo[c][2,7]naphthyridin-5-one Chemical compound CC(C)C[C@H](N)COC1=CC=2N(C)C(=O)C3=CN=CC=C3C=2C=C1C1CC1 JKZORRCCLSIZMM-HNNXBMFYSA-N 0.000 claims 1
- YTEFPJDHNWGEDV-HNNXBMFYSA-N 8-[(2s)-2-amino-4-methylpentoxy]-9-ethyl-6-methylbenzo[c][2,7]naphthyridin-5-one Chemical compound CN1C(=O)C2=CN=CC=C2C2=C1C=C(OC[C@@H](N)CC(C)C)C(CC)=C2 YTEFPJDHNWGEDV-HNNXBMFYSA-N 0.000 claims 1
- SYTLAGDWFIULBR-ZDUSSCGKSA-N 8-[(2s)-2-amino-4-methylpentoxy]-9-fluoro-4,6-dimethylbenzo[c][2,7]naphthyridin-5-one Chemical compound CN1C(=O)C2=C(C)N=CC=C2C2=C1C=C(OC[C@@H](N)CC(C)C)C(F)=C2 SYTLAGDWFIULBR-ZDUSSCGKSA-N 0.000 claims 1
- BVYQOYUERGMZOR-LBPRGKRZSA-N 8-[(2s)-2-amino-4-methylpentoxy]-9-fluoro-4-methyl-6h-benzo[c][2,7]naphthyridin-5-one Chemical compound N1C(=O)C2=C(C)N=CC=C2C2=C1C=C(OC[C@@H](N)CC(C)C)C(F)=C2 BVYQOYUERGMZOR-LBPRGKRZSA-N 0.000 claims 1
- UIIOSLHEZNMKMF-LBPRGKRZSA-N 8-[(2s)-2-amino-4-methylpentoxy]-9-fluoro-6-methylbenzo[c][2,7]naphthyridin-5-one Chemical compound CN1C(=O)C2=CN=CC=C2C2=C1C=C(OC[C@@H](N)CC(C)C)C(F)=C2 UIIOSLHEZNMKMF-LBPRGKRZSA-N 0.000 claims 1
- VBKPIQDGHTZSFR-LBPRGKRZSA-N 8-[(2s)-2-amino-4-methylpentoxy]-9-hydroxy-6-methylbenzo[c][2,7]naphthyridin-5-one Chemical compound CN1C(=O)C2=CN=CC=C2C2=C1C=C(OC[C@@H](N)CC(C)C)C(O)=C2 VBKPIQDGHTZSFR-LBPRGKRZSA-N 0.000 claims 1
- PWXKBOZXLHEXHI-AWEZNQCLSA-N 8-[(2s)-2-amino-4-methylpentoxy]-9-methoxy-4,6-dimethylbenzo[c][2,7]naphthyridin-5-one Chemical compound CN1C(=O)C2=C(C)N=CC=C2C2=C1C=C(OC[C@@H](N)CC(C)C)C(OC)=C2 PWXKBOZXLHEXHI-AWEZNQCLSA-N 0.000 claims 1
- CPDCVAWWRJBIEE-HNNXBMFYSA-N 8-[(2s)-2-amino-4-methylpentoxy]-n,n,4,6-tetramethyl-5-oxobenzo[c][2,7]naphthyridine-9-carboxamide Chemical compound CN1C(=O)C2=C(C)N=CC=C2C2=C1C=C(OC[C@@H](N)CC(C)C)C(C(=O)N(C)C)=C2 CPDCVAWWRJBIEE-HNNXBMFYSA-N 0.000 claims 1
- DRXIVOBMZNQSMK-YUZLPWPTSA-N 8-[(2s)-2-amino-5,5,5-trifluoro-4-methylpentoxy]-4,6-dimethylbenzo[c][2,7]naphthyridin-5-one Chemical compound N1=CC=C2C3=CC=C(OC[C@@H](N)CC(C)C(F)(F)F)C=C3N(C)C(=O)C2=C1C DRXIVOBMZNQSMK-YUZLPWPTSA-N 0.000 claims 1
- UDIIMGJDZJDIMZ-ZDUSSCGKSA-N 8-[(2s)-2-amino-5,5-difluoropent-4-enoxy]-4,6-dimethyl-5-oxobenzo[c][2,7]naphthyridine-9-carbonitrile Chemical compound C12=CC(C#N)=C(OC[C@@H](N)CC=C(F)F)C=C2N(C)C(=O)C2=C1C=CN=C2C UDIIMGJDZJDIMZ-ZDUSSCGKSA-N 0.000 claims 1
- JTJPHTSXEWEQPY-KSSFIOAISA-N 8-[(2s,3s)-3-amino-5-methylhexan-2-yl]oxy-4,6-dimethylbenzo[c][2,7]naphthyridin-5-one Chemical compound N1=CC=C2C3=CC=C(O[C@@H](C)[C@@H](N)CC(C)C)C=C3N(C)C(=O)C2=C1C JTJPHTSXEWEQPY-KSSFIOAISA-N 0.000 claims 1
- 208000024827 Alzheimer disease Diseases 0.000 claims 1
- 208000020925 Bipolar disease Diseases 0.000 claims 1
- 208000001640 Fibromyalgia Diseases 0.000 claims 1
- 208000018737 Parkinson disease Diseases 0.000 claims 1
- 108091000080 Phosphotransferase Proteins 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 239000003112 inhibitor Substances 0.000 claims 1
- 230000001404 mediated effect Effects 0.000 claims 1
- RUZLIIJDZBWWSA-INIZCTEOSA-N methyl 2-[[(1s)-1-(7-methyl-2-morpholin-4-yl-4-oxopyrido[1,2-a]pyrimidin-9-yl)ethyl]amino]benzoate Chemical group COC(=O)C1=CC=CC=C1N[C@@H](C)C1=CC(C)=CN2C(=O)C=C(N3CCOCC3)N=C12 RUZLIIJDZBWWSA-INIZCTEOSA-N 0.000 claims 1
- WMPDMMUFIRDMPA-AWEZNQCLSA-N n-[8-[(2s)-2-amino-4-methylpentoxy]-6-methyl-5-oxobenzo[c][2,7]naphthyridin-2-yl]acetamide Chemical compound N1=C(NC(C)=O)C=C2C3=CC=C(OC[C@@H](N)CC(C)C)C=C3N(C)C(=O)C2=C1 WMPDMMUFIRDMPA-AWEZNQCLSA-N 0.000 claims 1
- 208000033808 peripheral neuropathy Diseases 0.000 claims 1
- 239000008177 pharmaceutical agent Substances 0.000 claims 1
- 102000020233 phosphotransferase Human genes 0.000 claims 1
- 201000000980 schizophrenia Diseases 0.000 claims 1
- PCUUDYSYXFBLDS-UHFFFAOYSA-N tert-butyl n-[2,4-dimethyl-1-(6-methyl-5-oxobenzo[c][2,7]naphthyridin-8-yl)oxypentan-2-yl]carbamate Chemical compound N1=CC=C2C3=CC=C(OCC(C)(CC(C)C)NC(=O)OC(C)(C)C)C=C3N(C)C(=O)C2=C1 PCUUDYSYXFBLDS-UHFFFAOYSA-N 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261677856P | 2012-07-31 | 2012-07-31 | |
| US61/677,856 | 2012-07-31 | ||
| US13/946,344 | 2013-07-19 | ||
| US13/946,344 US8901305B2 (en) | 2012-07-31 | 2013-07-19 | Aryl lactam kinase inhibitors |
| PCT/US2013/051831 WO2014022167A1 (en) | 2012-07-31 | 2013-07-24 | Aryl lactam kinase inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2015528018A JP2015528018A (ja) | 2015-09-24 |
| JP2015528018A5 true JP2015528018A5 (enExample) | 2016-08-25 |
Family
ID=50026068
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015525460A Withdrawn JP2015528018A (ja) | 2012-07-31 | 2013-07-24 | アリールラクタムキナーゼ阻害剤 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US8901305B2 (enExample) |
| EP (1) | EP2880032B1 (enExample) |
| JP (1) | JP2015528018A (enExample) |
| CN (1) | CN104507941A (enExample) |
| AR (1) | AR093758A1 (enExample) |
| BR (1) | BR112015001890A2 (enExample) |
| CA (1) | CA2880523A1 (enExample) |
| EA (1) | EA201590268A1 (enExample) |
| ES (1) | ES2602965T3 (enExample) |
| MX (1) | MX2015000980A (enExample) |
| TW (1) | TW201410676A (enExample) |
| WO (1) | WO2014022167A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2958924B1 (en) | 2013-02-22 | 2016-12-28 | Bristol-Myers Squibb Company | 5h-chromeno[3,4-c]pyridines as inhibitors of adaptor associated kinase 1 (aak1) |
| WO2015006100A1 (en) | 2013-07-08 | 2015-01-15 | Bristol-Myers Squibb Company | Aryl amide kinase inhibitors |
| CN105979950A (zh) | 2013-10-11 | 2016-09-28 | 百时美施贵宝公司 | 吡咯并三嗪激酶抑制剂 |
| EA028587B1 (ru) * | 2014-01-29 | 2017-12-29 | Бристол-Майерс Сквибб Компани | Ариллактамные ингибиторы киназы |
| CA2944466C (en) * | 2014-04-02 | 2020-06-09 | Bristol-Myers Squibb Company | Biaryl kinase inhibitors |
| EP3292124B1 (en) * | 2015-04-10 | 2019-05-22 | Bristol-Myers Squibb Company | 6h-isochromeno[3,4-c]pyridines and benzo[c][1,7]naphthyridin-6-(5h)-ones as adaptor associated kinase 1 (aak1) inhibitors |
| ES2767776T3 (es) * | 2015-10-01 | 2020-06-18 | Bristol Myers Squibb Co | Inhibidores de biaril cinasa |
| CN112142655A (zh) * | 2015-10-01 | 2020-12-29 | 百时美施贵宝公司 | 联芳基激酶抑制剂 |
| US12636370B2 (en) * | 2019-08-08 | 2026-05-26 | Institute For Cancer Research | Combination therapy for treatment of cancer |
| CN114853664B (zh) * | 2022-06-02 | 2023-09-29 | 河南大学 | 一种钯催化条件下合成α,β-不饱和杂环己基酮类化合物的方法 |
| CN116102542A (zh) * | 2023-02-15 | 2023-05-12 | 如东众意化工有限公司 | 环丙唑醇精制母液中环丙唑醇的回收方法 |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5464764A (en) | 1989-08-22 | 1995-11-07 | University Of Utah Research Foundation | Positive-negative selection methods and vectors |
| WO1993004169A1 (en) | 1991-08-20 | 1993-03-04 | Genpharm International, Inc. | Gene targeting in animal cells using isogenic dna constructs |
| DK0672031T3 (da) | 1992-12-02 | 2003-06-10 | Pfizer | Catecholdiethere som selektive PDE IV-inhibitorer |
| US5709861A (en) | 1993-04-22 | 1998-01-20 | Emisphere Technologies, Inc. | Compositions for the delivery of antigens |
| AUPS137402A0 (en) * | 2002-03-26 | 2002-05-09 | Fujisawa Pharmaceutical Co., Ltd. | Novel tricyclic compounds |
| ATE388946T1 (de) | 2002-04-05 | 2008-03-15 | Boehringer Ingelheim Pharma | Cyanamide als reversible hemmer von cystein proteasen |
| WO2004056744A1 (en) | 2002-12-23 | 2004-07-08 | Janssen Pharmaceutica N.V. | Adamantyl acetamides as hydroxysteroid dehydrogenase inhibitors |
| EP1593667A4 (en) | 2003-02-12 | 2009-03-04 | Takeda Pharmaceutical | Amine derivative |
| WO2005000309A2 (en) | 2003-06-27 | 2005-01-06 | Ionix Pharmaceuticals Limited | Chemical compounds |
| JP2007523109A (ja) * | 2004-02-18 | 2007-08-16 | エフ．ホフマン−ラ ロシュ アーゲー | 複素環式Ｇａｂａ−Ａサブタイプ選択的レセプターモジュレーター |
| CA2570694A1 (en) | 2004-06-24 | 2006-02-02 | Incyte Corporation | Amido compounds and their use as pharmaceuticals |
| CN100494167C (zh) | 2005-08-02 | 2009-06-03 | 天津大学 | 抗乙肝病毒的叔胺氧化物及制备方法和制备药物的应用 |
| WO2007068465A1 (en) * | 2005-12-15 | 2007-06-21 | F. Hoffmann-La Roche Ag | Tricyclic lactam derivatives, their manufacture and use as pharmaceutical agents |
| JP2007217408A (ja) | 2006-01-19 | 2007-08-30 | Tanabe Seiyaku Co Ltd | 医薬組成物 |
| AU2007223342A1 (en) * | 2006-03-07 | 2007-09-13 | Bristol-Myers Squibb Company | Pyrrolotriazine aniline prodrug compounds useful as kinase inhibitors |
| JP5420395B2 (ja) | 2006-04-07 | 2014-02-19 | バーテックス ファーマシューティカルズ インコーポレイテッド | Ａｔｐ結合カセット輸送体の調節剤 |
| US20080040819A1 (en) | 2006-08-14 | 2008-02-14 | Wyeth | Methods of identifying agents for treatment of schizophrenia and related disorders |
| EP2094682A2 (en) * | 2006-12-22 | 2009-09-02 | Novartis AG | Heteroaryl-heteroaryl compounds as cdk inhibitors for the treatment of cancer, inflammation and viral infections |
| CA2761298A1 (en) * | 2009-05-15 | 2010-11-18 | The University Of Kentucky Research Foundation | Treatment of mci and alzheimer's disease |
| FR2955109B1 (fr) * | 2010-01-08 | 2012-09-07 | Sanofi Aventis | Derives de 5-oxo-5,8-dihydro-pyrido[2, 3-d]pyrimidine, leur preparation et leur application en therapeutique |
| EP2552922A1 (en) * | 2010-03-31 | 2013-02-06 | Bristol-Myers Squibb Company | Substituted pyrrolotriazines as protein kinase inhibitors |
| HK1199814A1 (en) | 2012-03-09 | 2015-07-24 | Lexicon Pharmaceuticals, Inc. | Inhibition of adaptor associated kinase 1 for the treatment of pain |
| RU2014140739A (ru) | 2012-03-09 | 2016-04-27 | Лексикон Фармасьютикалз, Инк. | Соединения на основе имидазо[1, 2-b]пиридазина, композиции таких соединений и способы их применения |
| DK2834243T3 (en) | 2012-03-09 | 2018-07-23 | Lexicon Pharmaceuticals Inc | Pyrazole [1,5-a] pyrimidine-based compounds, compositions comprising them and methods for their use |
| US8703953B2 (en) | 2012-03-09 | 2014-04-22 | Bristol-Myers Squibb Company | Aryl ether-base kinase inhibitors |
-
2013
- 2013-07-19 US US13/946,344 patent/US8901305B2/en active Active
- 2013-07-24 CA CA2880523A patent/CA2880523A1/en not_active Abandoned
- 2013-07-24 ES ES13744927.8T patent/ES2602965T3/es active Active
- 2013-07-24 MX MX2015000980A patent/MX2015000980A/es unknown
- 2013-07-24 BR BR112015001890A patent/BR112015001890A2/pt not_active Application Discontinuation
- 2013-07-24 EA EA201590268A patent/EA201590268A1/ru unknown
- 2013-07-24 EP EP13744927.8A patent/EP2880032B1/en active Active
- 2013-07-24 JP JP2015525460A patent/JP2015528018A/ja not_active Withdrawn
- 2013-07-24 CN CN201380041073.9A patent/CN104507941A/zh active Pending
- 2013-07-24 WO PCT/US2013/051831 patent/WO2014022167A1/en not_active Ceased
- 2013-07-30 TW TW102127296A patent/TW201410676A/zh unknown
- 2013-07-31 AR ARP130102716A patent/AR093758A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20121069T1 (hr) | Supstituirani derivati amida kao inhibitori protein kinaze | |
| RU2014152790A (ru) | Пирролопиразоновые ингибиторы танкиразы | |
| JP2016515098A5 (enExample) | ||
| RU2015148189A (ru) | ПРОИЗВОДНЫЕ 2-АМИДОПИРИДО[4, 3-d]ПИРИМИДИН-5-ОНА И ИХ ПРИМЕНЕНИЕ В КАЧЕСТВЕ ИНГИБИТОРОВ WEE-1 | |
| JP2017503840A5 (enExample) | ||
| SI2751083T1 (en) | Quinolone compound | |
| RU2018103944A (ru) | Производные этинила как модуляторы метаботропного рецептора глутамата | |
| RU2018121499A (ru) | Гипоксантины в качестве ингибиторов убиквитин-специфической протеазы 1 | |
| PE20130188A1 (es) | Pirrolidinonas heteroaromaticas fusionadas como inhibidores de syk | |
| RU2009113612A (ru) | Ацетамидные производные хиназолинона и изохинолинона | |
| JP2017537949A5 (enExample) | ||
| JP2019517996A5 (enExample) | ||
| RU2014115476A (ru) | Производные пиразоло[4, 3-с]птридина в качестве ингибиторов киназ | |
| JP2017531039A5 (enExample) | ||
| RU2016146365A (ru) | Новые дигидрохинолизиноны для лечения и профилактики заражения вирусом гепатита b | |
| RU2016110096A (ru) | Новое хинолин-замещенное соединение | |
| RU2018134981A (ru) | Конъюгаты, содержащие ингибиторы RIPK2 | |
| AR067413A1 (es) | Compuestos heterociclicos que contienen ciclopenta[d]pirimidina inhibidores de proteinquinasas akt, composiciones farmaceuticas que los contienen, metodo de preparacion y uso de las mismas para el tratamiento de enfermedades hiperproliferativas, tales como cancer | |
| RU2018133391A (ru) | 1,5-дигидро-4н-пиразоло[3,4-d]пиримидин-4-оны и 1,5-дигидро-4н-пиразоло[4,3-c]пиридин-4-оны в качестве ингибиторов pde1 | |
| JP2016525075A5 (enExample) | ||
| JP2016511258A5 (enExample) | ||
| HRP20201094T1 (hr) | IMIDAZO[1,2-a]PIRIDINI, NAMIJENJENI LIJEČENJU ILI SPRJEČAVANJU HIPERURIKEMIJE ILI GIHTA | |
| RU2014109748A (ru) | Морфолино-замещенные производные бициклических пиримидинмочевины или карбамата в качестве ингибиторов mtor | |
| RU2016134751A (ru) | Соединения | |
| AR075951A1 (es) | Dihidropiridin sulfonamidas y dihidropiridin sulfamidas como inhibidores de mek |